Antitumor compositions for non-injection administration
US4542021A · kind A · utility
7Cited by
0References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 10, 1980 |
| Grant date | Sep 17, 1985 |
| Priority date | — |
| Expiry date | Nov 10, 2000 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An antitumor composition comprising a pharmacologically effective quantity of an ester of 1-.beta.-D-arabinofuranosylcytosine-5'-phosphate represented by the general formula ##STR1## where R is a monovalent aliphatic hydrocarbon group having 14 to 23 carbon atoms, and A designates a hydrogen atom or a pharmaceutically-acceptable alkali cation, and a vehicle is effective when administered by a non-injection method, particularly orally.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.